Patients Why patient safety doesn't end at approval Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
Patients Why Britain's blood tests are only as reliable as the journe... What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned
Sales & Marketing Why trust is becoming pharma’s most important visibility met... Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.
Market Access Fighting fake GLP-1s to protect patients & preserve trust Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.
Patients Every child deserves safe care from day one Patient safety remains one of the most pressing global health challenges of our time.
Patients Strengthening safety: The critical role of reliable labellin... Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
